Clichés aside, sometimes law really is a relationship business. Consider Kirkland & Ellis’s role in Teva Pharmaceutical Industries Limited’s $6.8 billion acquisition of Cephalon, Inc., the biggest M&A deal of the year involving the United States and an emerging market.
Kirkland had long represented Teva, which is based in Petah Tikva, Israel, in litigation matters, but for transactions, Teva more commonly turned to Willkie Farr & Gallagher. For instance, when Teva acquired Montvale, New Jersey’s Barr Pharmaceuticals, Inc., for $7.5 billion in 2008, Willkie was Teva’s primary outside counsel.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
